Technical Entity Trends: A Cure May Stem From Your Cells

February
,
2017

Before her first birthday, Layla Richards was diagnosed with an aggressive form of leukemia. After chemotherapy and a bone marrow transplant failed to cure her, she was treated in 2015 with engineered T-cells. The treatment eradicated all traces of leukemia in her body.

Although cell therapies, such as those that employ T-cells, have been used for years, engineered stem cells are now tackling some of the same harmful conditions. In June 2016, a leukemia patient named Chuck Dandridge became the first adult in the U.S. to receive a newly modified stem cell transplant that uses genetically engineered blood cells from a family member. The engineered blood cells were transplanted from his son, and his leukemia is now in remission.

Stem cell engineering has the potential to take on many diseases, disorders, and conditions. Engineers and researchers in the field produce regenerative cellular therapies and treatments as well as diagnostic tools for treating and identifying diseases, such as blood disorders, cancers, retina disorders, and more. Stem cells can be derived from embryos (embryonic stem cells), from adult tissue (adult stem cells), or by reprogramming adult cells to behave as if they were embryonic stem cells (induced pluripotent stem cells). Induced pluripotent stem (iPS) cells have tremendous potential for regenerative medicine, because they enable the creation of patient-specific, immunologically matched stem cells without involving embryos.

There are still major challenges to address before stem cells can be widely applied as a therapy. Our understanding of the molecular mechanisms that underlie stem cell potency, self-renewal, and differentiation is still incomplete. New interdisciplinary bioengineering strategies for stem cell production, characterization, growth, purification, and delivery are needed. Novel approaches and technologies are also needed to rapidly accelerate the translation of stem cell discoveries into cellular and molecular therapies and in vitro diagnostic platforms.

images

Pluripotent stem cells can generate many other types of cells, including muscle, blood, and neural cells.

Several areas of stem cell research and engineering could benefit from an integrated approach that involves biologists and engineers from academia and industry. Stem cells are exposed to various physical, mechanical, and chemical stimuli during development and regeneration. For example, in ischemic disorders, injured blood vessels are exposed to low oxygen supply and low shear stress (unlike healthy vasculature, which is exposed to high oxygen levels and high shear stress). Engineering fundamentals such as transport phenomena and mechanical force could help us better understand and control stem cell responses.

Recent advances in biomimetic systems could be used to recreate the developing or regenerating environment in vitro. Bioreactors, microfluidics, and scaffolds provide control over a variety of microenvironment conditions. Studying these culture systems may help researchers to better understand human stem cell morphogenesis, as well as enable testing of various therapeutic targets and the development of computational and mathematical predictive models.

In vivo stimulation of regenerative pathways is being studied as an alternative approach to stem cell transplantation. A patient’s own stem cells could be recruited to the injured tissue to regenerate and heal the surrounding cells. Triggering this healing mechanism would involve chemical stimulation, as well as the use of specially designed biomaterials to induce interactions between the injured tissue and the patient’s immune system.

Scaleup of therapeutic technologies developed in academic laboratories will require new and/or improved bioprocesses and manufacturing practices that are suitable for clinical applications. Clinical testing of therapeutics and feedback from clinicians is critical to advancing therapeutics beyond the bench.

Biologists, engineers, and biochemists will need to collaborate and train one another in complementary viewpoints to realize the full potential of stem cells. The Society for Biological Engineering (SBE) recently held several conferences that covered topics related to stem cell engineering, including the International Conference on Stem Cell Engineering in October 2016, the Translational Medicine and Bioengineering Conference in November 2016, and the Rock Stars of Regenerative Engineering in December 2016. SBE is organizing several conferences in 2018 that will discuss topics related to stem cell engineering, including the next International Conference on Stem Cell Engineering.

1

image

Author Bios: 

Gabriel Levesque-Tremblay

Dr. Gabriel Levesque-Tremblay the Director for Technical Entities and Grants. Prior to joining AIChE, Dr. Levesque-Tremblay was a Post-Doctoral Fellow at University of California, Berkeley (UCB) working on Synthetic Biology Projects at the Energy Biosciences Institute. He holds a PhD from University of British Columbia (UBC), a Master and a Bachelor in Science from University of Quebec in Montreal.

At AIChE Dr. Levesque-Tremblay supports the strategic activities of 12 executive boards and societies including the Society for Biological Engineering (SBE), the Institute for...Read more

Copyright Permissions: 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.